Endocrinology Testing - Mayo Clinic Laboratories
Standardization of procedures and protocols is essential for the reliable interpretation of dynamic endocrine testing results. Our test menu includes more than 70 common and esoteric analytes and is constantly growing.
Learn more about how Mayo Clinic Laboratories’ testing can assist in diagnosis and differentiation of porphyrias and help guide treatment decisions
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
Organic acid disorders - Insights
Check out how Mayo Clinic Laboratories testing for organic acid metabolism disorders can help provide early diagnosis that enable prompt intervention.
Cardiovascular Pathology Services at Mayo Clinic Laboratories
Cardiovascular pathology focuses on a multidisciplinary approach to the consultative practice. Learn more about our service.
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.
Confirmatory testing - Insights
Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.
Outreach Quality and Satisfaction - The Patient's View - Insights
As healthcare continues to evolve and payment models become more inclusive of patient satisfaction measures, it is vitally important for laboratories to focus on improving the patient experience. Because the laboratory is a critical element...
Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in...
Hereditary Oncology Testing [Test in Focus] - Insights
Wei Shen, Ph.D., explains Mayo Clinic Laboratories' new expert-backed, hereditary oncology panels, which use next-generation sequencing to identify genetic mutations linked to increased cancer risk. By only including clinically significant...